{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:56:32Z","timestamp":1793040992732,"version":"4.5.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Walking speed is a key measure of health and mobility across a wide range of diseases. Traditional gait assessments in clinical settings may not accurately reflect real-world mobility patterns. Wearable sensors offer an ecologically valid alternative by capturing every movement in daily life, but there are few robust, validated reports. We aimed to identify evidence on real-world gait speed measurements that have received or are seeking regulatory approval from agencies such as the European Medicines Agency and the U.S. Food and Drug Administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We conducted a systematic review following a comprehensive search strategy using the Ovid platform, guided by pre-defined selection criteria and in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. We also manually searched the websites of key regulatory agencies and the ClinicalTrials.gov database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our search identified 503 records, of which 10 met the inclusion criteria. Most studies were part of large-scale initiatives, including the qualification of the Stride Velocity 95th Centile and the MOBILISE-D project. No device or outcome measure that assesses walking speed in real-world conditions has been fully validated by the FDA. We found four letters of intent on the FDA website related to this concept. One outcome, the 95th centile of stride velocity, has been approved by the EMA as a primary endpoint for assessing ambulant patients with Duchenne Muscular Dystrophy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite the potential of wearable devices to enhance drug development and clinical decision-making, real-world walking speed remains insufficiently validated across most conditions because data is missing. The widespread adoption of digital outcomes to assess ambulation will require extensive validation efforts, regulatory pathway adaptations, and improved standardization of devices, algorithms, and study methodologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42025633578<\/jats:ext-link>\n                      , PROSPERO CRD42025633578.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fdgth.2026.1726549","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:45:02Z","timestamp":1771332302000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Real-world walking speed as a digital biomarker and outcome measure for clinical trials\u2014a systematic review, regulatory status and future directions"],"prefix":"10.3389","volume":"8","author":[{"given":"Margaux","family":"Poleur","sequence":"first","affiliation":[{"name":"University Department of Neurology, Citadelle Hospital","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Tychon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Else Kr\u00f6ner Fresenius Center for Digital Health, TUD Dresden University of Technology","place":["Dresden, Germany"]},{"name":"Faculty of Business and Economics, TUD Dresden University of Technology","place":["Dresden, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Daumer","sequence":"additional","affiliation":[{"name":"SLCMSR E.V. - The Human Motion Institute","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Servais","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, MDUK Oxford Neuromuscular Centre, University of Oxford","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3233\/NRE-182467","article-title":"The effects of balance and gait function on quality of life of stroke patients","volume":"44","author":"Park","year":"2019","journal-title":"NeuroRehabilitation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/B978-0-444-63916-5.00007-0","article-title":"Gait","volume":"159","author":"Mirelman","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/135245859900500409","article-title":"The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment","volume":"5","author":"Fischer","year":"1999","journal-title":"Mult Scler"},{"key":"B4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mus.23905","article-title":"The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study","volume":"48","author":"Mcdonald","year":"2013","journal-title":"Muscle Nerve"},{"key":"B5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS Statement: guidelines for the six-minute walk test","volume":"166","author":"Crapo","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/mds.21879","article-title":"The evolution of disability in Parkinson disease","volume":"23","author":"Shulman","year":"2008","journal-title":"Mov Disord"},{"key":"B7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s12872-020-01725-5","article-title":"Physical functional performance and prognosis in patients with heart failure: a systematic review and meta-analysis","volume":"20","author":"Fuentes-Abolafio","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"B8","doi-asserted-by":"publisher","first-page":"989622","DOI":"10.3389\/fneur.2022.989622","article-title":"Walking speed at the acute and subacute stroke stage: a descriptive meta-analysis","volume":"13","author":"Tasseel-Ponche","year":"2022","journal-title":"Front Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.14423\/SMJ.0000000000001318","article-title":"Walking speed and mortality: an updated systematic review","volume":"114","author":"Rosmaninho","year":"2021","journal-title":"South Med J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1080\/02640414.2024.2390302","article-title":"Dose-response association between walking speed and all-cause mortality: a systematic review and meta-analysis of cohort studies","volume":"42","author":"Liu","year":"2024","journal-title":"J Sports Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/jgs.15312","article-title":"Walking speed, cognitive function, and dementia risk in the English longitudinal study of ageing","volume":"66","author":"Hackett","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40263-017-0412-5","article-title":"Outcome measures in clinical trials for multiple sclerosis","volume":"31","author":"van Munster","year":"2017","journal-title":"CNS Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1001\/jamaneurol.2023.0552","article-title":"Efficacy and safety of avalglucosidase alfa in patients with late-onset pompe disease after 97 weeks: a phase 3 randomized clinical trial","volume":"80","author":"Kishnani","year":"2023","journal-title":"JAMA Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41531-023-00585-y","article-title":"Overview on wearable sensors for the management of Parkinson\u2019s disease","volume":"9","author":"Moreau","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13023-023-02813-3","article-title":"The use of digital outcome measures in clinical trials in rare neurological diseases: a systematic literature review","volume":"18","author":"Poleur","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e44428","DOI":"10.2196\/44428","article-title":"Wearable sensor technologies to assess motor functions in people with multiple sclerosis: systematic scoping review and perspective","volume":"25","author":"Woelfle","year":"2023","journal-title":"J Med Internet Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/cpt.3398","article-title":"Regulatory pathways for qualification and acceptance of digital health technology-derived clinical trial endpoints: considerations for sponsors","volume":"117","author":"Bakker","year":"2025","journal-title":"Clin Pharmacol Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"Br Med J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.2196\/mhealth.9341","article-title":"Recommendations for assessment of the reliability, sensitivity, and validity of data provided by wearable sensors designed for monitoring physical activity","volume":"6","author":"D\u00fcking","year":"2018","journal-title":"JMIR Mhealth Uhealth"},{"key":"B20","year":""},{"key":"B21","year":""},{"key":"B22","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1038\/s41591-023-02459-5","article-title":"First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMD","volume":"29","author":"Servais","year":"2023","journal-title":"Nat Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"29681","DOI":"10.1038\/s41598-024-80177-9","article-title":"Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint","volume":"14","author":"Servais","year":"2024","journal-title":"Sci Rep"},{"key":"B24","year":""},{"key":"B25","year":""},{"key":"B26","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3233\/JPD-230044","article-title":"Can digital mobility assessment enhance the clinical assessment of disease severity in Parkinson\u2019s disease?","volume":"13","author":"Kirk","year":"2023","journal-title":"J Parkinsons Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.21203\/rs.3.rs-178075\/v1","article-title":"Normative data on spontaneous stride velocity, stride length, and walking activity in a non-controlled environment","volume":"16","author":"Poleur","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.nmd.2019.06.003","article-title":"European Regulators\u2019 views on a wearable-derived performance measurement of ambulation for duchenne muscular dystrophy regulatory trials","volume":"29","author":"Haberkamp","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e15191","DOI":"10.2196\/15191","article-title":"Continuous digital monitoring of walking speed in frail elderly patients: noninterventional validation study and longitudinal clinical trial","volume":"7","author":"Mueller","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"key":"B30","year":""},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0221732","DOI":"10.1371\/journal.pone.0221732","article-title":"Validity of accelerometry in step detection and gait speed measurement in orthogeriatric patients","volume":"14","author":"Keppler","year":"2019","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.gaitpost.2011.09.005","article-title":"Accuracy of the actibelt\u00ae accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis","volume":"35","author":"Motl","year":"2012","journal-title":"Gait Posture"},{"key":"B33","year":""},{"key":"B34","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/14737175.2018.1503948","article-title":"Role of the personal KinetiGraph in the routine clinical assessment of Parkinson\u2019s disease: recommendations from an expert panel","volume":"18","author":"Pahwa","year":"2018","journal-title":"Expert Rev Neurother"},{"key":"B35","doi-asserted-by":"publisher","first-page":"574443","DOI":"10.3389\/fped.2020.574443","article-title":"Accelerometric gait analysis devices in children\u2014will they accept them? Results from the AVAPed study","volume":"8","author":"Wiedmann","year":"2020","journal-title":"Front Pediatr"},{"key":"B36","year":""},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0269615","DOI":"10.1371\/journal.pone.0269615","article-title":"Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement\u2013the mobilise-D study protocol","volume":"17","author":"Mikolaizak","year":"2022","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00415-016-8334-6","article-title":"Continuous daily assessment of multiple sclerosis disability using remote step count monitoring","volume":"264","author":"Block","year":"2017","journal-title":"J Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1007\/s11357-024-01471-y","article-title":"Association of the interaction between daily step counts and frailty with disability in older adults","volume":"47","author":"Watanabe","year":"2024","journal-title":"Geroscience"},{"key":"B40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/mds.27671","article-title":"A roadmap for implementation of patient-centered digital outcome measures in Parkinson\u2019s disease obtained using mobile health technologies","volume":"34","author":"Espay","year":"2019","journal-title":"Mov Disord"},{"key":"B41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41746-020-0260-4","article-title":"Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for biometric monitoring technologies (BioMeTs)","volume":"3","author":"Goldsack","year":"2020","journal-title":"NPJ Digit Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jbiomech.2023.111555","article-title":"Influence of the Hawthorne effect on spatiotemporal parameters, kinematics, ground reaction force, and the symmetry of the dominant and nondominant lower limbs during gait.","author":"Jeon","year":"2023"},{"key":"B43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.drudis.2018.07.001","article-title":"How soon will digital endpoints become a cornerstone for future drug development?","volume":"24","author":"Boehme","year":"2019","journal-title":"Drug Discov Today."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3791\/59668","article-title":"Home-based monitor for gait and activity analysis.","author":"Lilien","year":"2019","journal-title":"J Vis Exp."},{"key":"B45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000517411","article-title":"First regulatory qualification of a novel digital endpoint in Duchenne muscular dystrophy: a multi-stakeholder perspective on the impact for patients and for drug development in neuromuscular diseases.","volume":"5","author":"Servais","year":"2021","journal-title":"Digit Biomark."},{"key":"B46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/mus.27446","article-title":"Home-based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy.","volume":"65","author":"Gidaro","year":"2022","journal-title":"Muscle Nerve."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/s41598-024-51766-5","article-title":"Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device.","volume":"14","author":"Kirk","year":"2024","journal-title":"Sci Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12966-025-01851-3","article-title":"Digital assessment of real-world walking in people with impaired mobility: how many hours and days are needed?","author":"Buekers","year":"2025","journal-title":"Int J Behav Nutr Phys Act."}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1726549\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:45:03Z","timestamp":1771332303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1726549\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":48,"alternative-id":["10.3389\/fdgth.2026.1726549"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2026.1726549","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"article-number":"1726549"}}